MHE Publication
MHE February 2024
Volume: 34
Issue: 2
MHE January 2024
Volume: 34
Issue: 1
MHE December 2023
Volume: 33
Issue: 12
MHE November 2023
Volume: 33
Issue: 11
MHE October 2023
Volume: 33
Issue: 10
MHE September 2023
Volume: 33
Issue: 9
MHE August 2023
Volume: 33
Issue: 8
MHE July 2023
Volume: 33
Issue: 7
MHE June 2023
Volume: 33
Issue: 6
MHE May 2023
Volume: 33
Issue: 5
MHE April 2023
Volume: 33
Issue: 4
MHE March 2023
Volume: 33
Issue: 03
MHE February 2023
Volume: 33
Issue: 2
MHE January 2023
Volume: 33
Issue: 1
MHE December 2022
Volume: 32
Issue: 12
MHE November 2022
Volume: 32
Issue: 11
MHE October 2022
Volume: 32
Issue: 10
MHE September 2022
Volume: 32
Issue: 9
MHE August 2022
Volume: 32
Issue: 8
MHE July 2022
Volume: 32
Issue: 7
MHE June 2022
Volume: 32
Issue: 6
MHE May 2022
Volume: 32
Issue: 5
MHE April 2022
Volume: 32
Issue: 4
MHE March 2022
Volume: 32
Issue: 3
MHE February 2022
Volume: 32
Issue: 2
MHE January 2022
Volume: 32
Issue: 1
MHE December 2021
Volume: 31
Issue: 12
MHE November 2021
Volume: 31
Issue: 11
MHE October 2021
Volume: 31
Issue: 10
MHE September 2021
Volume: 31
Issue: 9
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
500,000 Medicaid beneficiaries with diabetes to lose coverage by 2034
2
Ashley Holzworth-Nash, Pharm.D., Evernorth
3
Adalimumab grabs top spot as most cost-efficient biologic for hidradenitis suppurativa
4
Does Medicare’s drug price negotiation disincentivize biosimilar development?
5